Masaaki Ichinoe
6PUBLICATIONS
6CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Jan 12, 2026
CD109 Expression in Tumor and Stromal Cells Serves as a Prognostic Biomarker for Tumor Progression and Outcome in Gallbladder Adenocarcinoma.Taro Kogami, Masaaki Ichinoe, Yasutaka Sakurai
|Jun 04, 2025
REV7 subunit of mutagenic DNA polymerase ζ as a predictive biomarker for the efficacy of immune checkpoint inhibitor therapy in melanoma.Akiyoshi Hoshino, Koya Obara, Masaaki Ichinoe
|Jul 15, 2024
Tumor thickness as a novel risk factor for lymph node metastasis by superficial squamous cell carcinoma of head and neck.Satoshi Fujii, Chikatoshi Katada, Hidenobu Watanabe
|Dec 22, 2023
REV7 is involved in outcomes of platinum-based chemotherapy in pancreatic cancer by controlling the DNA damage response.Akihiro Tamaki, Takuya Kato, Yasutaka Sakurai
|May 15, 2021
Transoral surgery for superficial head and neck cancer: National Multi-Center Survey in Japan.Chikatoshi Katada, Manabu Muto, Satoshi Fujii
|Sep 10, 2020
Prognostic values of L-type amino acid transporter 1 and CD98hc expression in breast cancer.Masaaki Ichinoe, Tetuo Mikami, Nobuyuki Yanagisawa
Pageof 1
